Gilead Sciences, Inc.
Hedge Funds Holdings
Last updated:
Gilead Sciences, Inc.‘s stocks are currently a part of 1538 hedge funds’ portfolios, which represents 77.29% of the total amount of its stocks outstanding. This makes up a total of 975.42M shares of Gilead Sciences, Inc.. Compared to the previous quarter, the number fell by -3.20% or -32.27M shares fewer. As for the holding position changes, 44.02% (677) of current hedge fund investors increased the number of shares held, 34.98% (538) of current holders sold a part of the shares held, and 13.65% (210) closed the holdings completely. 142 hedge funds are new holders of Gilead Sciences, Inc. stock in Q1 2022, it is 9.23% of total holders.
Hedge funds holding Gilead Sciences (Q2 2017 – Q1 2022)
| Q2 2017 | 1,507 |
|---|---|
| Q3 2017 | 1,490 |
| Q4 2017 | 1,559 |
| Q1 2018 | 1,549 |
| Q2 2018 | 1,506 |
| Q3 2018 | 1,511 |
| Q4 2018 | 1,478 |
| Q1 2019 | 1,470 |
| Q2 2019 | 1,460 |
| Q3 2019 | 1,441 |
| Q4 2019 | 1,528 |
| Q1 2020 | 1,615 |
| Q2 2020 | 1,594 |
| Q3 2020 | 1,512 |
| Q4 2020 | 1,527 |
| Q1 2021 | 1,527 |
| Q2 2021 | 1,505 |
| Q3 2021 | 1,523 |
| Q4 2021 | 1,634 |
| Q1 2022 | 1,538 |
Hedge funds changes in Gilead Sciences positions (Q2 2017 – Q1 2022)
| Q2 2017 | 109 | 582 | 657 | 95 | 64 |
|---|---|---|---|---|---|
| Q3 2017 | 121 | 596 | 608 | 121 | 44 |
| Q4 2017 | 199 | 535 | 682 | 117 | 26 |
| Q1 2018 | 124 | 570 | 688 | 112 | 55 |
| Q2 2018 | 74 | 542 | 717 | 108 | 65 |
| Q3 2018 | 90 | 536 | 688 | 72 | 125 |
| Q4 2018 | 147 | 443 | 725 | 163 | 0 |
| Q1 2019 | 113 | 601 | 597 | 110 | 49 |
| Q2 2019 | 107 | 561 | 644 | 101 | 47 |
| Q3 2019 | 88 | 579 | 593 | 95 | 86 |
| Q4 2019 | 174 | 500 | 687 | 73 | 94 |
| Q1 2020 | 251 | 623 | 620 | 144 | -23 |
| Q2 2020 | 153 | 622 | 675 | 159 | -15 |
| Q3 2020 | 110 | 603 | 627 | 176 | -4 |
| Q4 2020 | 199 | 511 | 679 | 174 | -36 |
| Q1 2021 | 140 | 624 | 592 | 127 | 44 |
| Q2 2021 | 106 | 640 | 552 | 119 | 88 |
| Q3 2021 | 117 | 607 | 578 | 86 | 135 |
| Q4 2021 | 229 | 634 | 582 | 102 | 87 |
| Q1 2022 | 142 | 677 | 538 | 210 | -29 |
Hedge funds changes in Gilead Sciences stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 16,685,782,932 | 3,342,678,977 |
|---|---|---|
| Q3 2017 | 7,885,126,144 | 5,623,927,725 |
| Q4 2017 | 5,579,035,748 | 21,644,841,828 |
| Q1 2018 | 42,626,303,099 | 703,884,017,934 |
| Q2 2018 | 1,240,654,872 | 3,801,399,232 |
| Q3 2018 | 1,208,966,627 | 2,649,096,319 |
| Q4 2018 | 1,061,034,955 | 1,327,448,790 |
| Q1 2019 | 825,607,727 | 1,070,543,182 |
| Q2 2019 | 847,407,888 | 1,066,125,156 |
| Q3 2019 | 760,429,102 | 1,137,151,212 |
| Q4 2019 | 1,396,524,824 | 3,463,270,226 |
| Q1 2020 | 2,401,498,004 | 7,960,731,264 |
| Q2 2020 | 381,039,769,388 | 536,040,469,166 |
| Q3 2020 | 4,172,499,306,607 | 5,896,885,016,692 |
| Q4 2020 | 1,961,441,472,182 | 2,586,711,693,752 |
| Q1 2021 | 1,720,880,727 | 1,594,619,315 |
| Q2 2021 | 1,702,623,784 | 1,539,279,128 |
| Q3 2021 | 1,615,401,250 | 1,667,344,865 |
| Q4 2021 | 1,825,923,771 | 2,011,436,002 |
| Q1 2022 | 1,358,786,790 | 1,212,221,420 |